Previous studies have identified elevated plasma Lp(a) concentrations (> 30 mg/dL) as a risk factor for a variety of atherosclerotic and thrombotic vascular diseases including peripheral vascular disease, venous thromboembolism, recurrent thrombotic stroke in children, and coronary heart disease (CHD) [35]. This evidence concerns the gene LPA and peripheral vascular disease.